Cite
HARVARD Citation
Cunquero-Tomás, A. et al. (2020). Safe neoadjuvant trastuzumab-based treatment in HER2 + inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature. Journal of oncology pharmacy practice. pp. 492-495. [Online].